NEW MEXICO Office of Substance Prevention ASSESSMENT TRAINING November 17, 2014 Albuquerque, New Mexico PARTICIPANT MANUAL Presented by: Natalie Skogerboe, MPA, CPS – Coop Consulting & Elizabeth Lilliott, PhD – Pacific Institute for Research and Evaluation This training was adapted from an earlier training developed by Feathers of Kamama Consulting for the NM Office of Substance Abuse Prevention. The assessment tools and assessment report were created by Natalie Skogerboe (Coop Consulting), Elizabeth Lilliott, and Martha Waller (both of PIRE). Funding for this training is from the NM Behavioral Health Services/Office of Substance Abuse Prevention. For questions please contact: Karen Cheman, MPH (Staff Manager, NPN & SEOW Director), Office of Substance Abuse Prevention, BHSD/HSD, 37 Plaza La Prensa, Santa Fe, NM 87507, 505-476-9270. karen.cheman@state.nm.us www.nmprevention.org Assessment Training Agenda November 17, 2014 Time Welcome & Introductions 9:00 Assessment Overview & Activity 9:15 Overview of Strategic Prevention Framework 9:30 Review of Assessment Report 10:00 Review of Logic Models 10:30 Review of New Mexico Community Survey Data 11:30 Lunch (on your own) 12:00 County Data Collection (Review of Tools) 1:00 Qualitative Data Collection Guidance 1:30 Focus Group Practice 2:00
Prescription Drug Logic Model + Data Sources Problem Behavior Intervening Variables Contributing Factors Possible Data Sources Social Access Family members / friends provide access unintentionally Community Survey (Q28, Q29, Q30) Focus Groups / Interviews Family members / friends provide access intentionally Retail Access Health care providers over-prescribe pain medications Community Survey (Q27, Q28, , PDMP, Focus Groups (parents, youth, Drs, etc) Dr / Pharmacy shopping place Access to International drug market Border Patrol, HIDTA, Comm Survey (Q28), Law Enf/Campus police, groups Illegal sales in the community Prescription Drug Misuse / Abuse Low Enforcement Prescription monitoring systems are not used effectively to deter misuse PDMP Focus Group/Interviews with law enf, students, Drs, pharmacists Lack of strong laws/regulations around prescribing practices/sales Perceived Risk Perception that if it is prescribed, law enforcement cannot do anything Community Survey Groups / Interviews Low perception of getting caught for over-prescribing or Dr / pharm shopping Prescription drugs are seen as safe Price High leads to accessing Rx through other means and possible switch over to heroin Focus groups (students, law enf, consumers) Community Norms Culture that encourages use of Rx for any ailment Community Survey (Q27) Focus Groups / Interviews Individual Factors Chronic / acute pain requires use Community Survey (Q27), Focus Groups / Interviews Past addiction makes individuals more susceptible to abuse Rx pain meds
Health Care Provider Survey Please indicate which title best describes you by circling the most appropriate title: Primary Care Physician Physician’s Assistant Pharmacist Nurse Specialty Dr (please specify) (please specify): DIRECTIONS: Please circle the best response for each question. Please select only 1 response. Q1 About how frequently are providers in your community asked to address a patient's pain management concerns during an average work week? Nearly Everyday Several a week Several times a month Rarely Almost Never Q2 If a patient presents with pain concerns, how likely are providers to suggest an over-the-counter pain medication such as ibuprofen or acetaminophen? (as the first option) Very likely Somewhat likely Neither likely nor unlikely Somewhat unlikely Very unlikely Q3 If a patient presents with pain concerns, how likely are providers to prescribe an opioid pain killer? (as the first option) Very likely Somewhat likely Neither likely nor unlikely Somewhat unlikely Very unlikely Q4 When prescribing opioid pain killers to a patient… Q4a … how likely are providers to inquire about the patient’s past opioid use? Very likely Somewhat likely Neither likely nor unlikely Somewhat unlikely Very unlikely Q4b … how likely are providers to inquire about any past problems the patient may have with substance use or addiction? Very likely Somewhat likely Neither likely nor unlikely Somewhat unlikely Very unlikely Q4c … how likely are providers to review the patient's for previous opioid prescriptions? Very likely Somewhat likely Neither likely nor unlikely Somewhat unlikely Very unlikely Q4d ... how likely are Doctors to check the Prescription Drug Monitoring data base for previous opioid prescriptions given to the patient? Very likely Somewhat likely Neither likely nor unlikely Somewhat unlikely Very unlikely Q4d ... how likely are other providers to check the Prescription Drug Monitoring data base for previous opioid prescriptions given to the patient? Very likely Somewhat likely Neither likely nor unlikely Somewhat unlikely Very unlikely
New Mexico – Office of Substance Abuse Prevention – Assessment Guide Population Items to be assessed Tool / Data Source Who will collect this? Where? From Whom? What is the timeframe? (12-20) Conduct at least 1 FG UAD (retail availability, social access, perceived risk, norms / beliefs) YRRS NSDUH (18-20yrs)? CS (18-20yr olds) Group Rx Misuse YRRS (12-17yrs) (18-25yrs)? CS Group Youth (21-25) Conduct at least 1 FG Binge/Excessive Drinking, Drinking & Driving CS Focus Group Rx Misuse CS Focus Group Parents / Community Members at large Conduct at least 1 FG UAD, Binge Drinking, DWI CS Focus Group Rx Misuse CS Focus Group Physicians & Pharmacists Conduct at least 3 Interviews (or 1 FG) UAD & Binge Drinking Interviews / Focus Groups? Rx Misuse (ID Dr/Pharm shopping, contributors to over-prescribing, PDMP Interviews / Groups? Med Provider Survey? Law Enforcement Conduct at least 3 Interviews (or 1 FG) UAD, Binge Drinking, DWI Focus Group/ Interview Rx Misuse Focus Group/ Interview CS = Community Survey, NSDUH = National Household Survey on Drug Use and Health, YRRS = Youth Risk & Resiliency Survey